Selected article for: "clinical disease and GI disease"

Title: 2016 ACVIM Forum Research Abstract Program
  • Document date: 2016_5_31
  • ID: 2y1y8jpx_256
    Snippet: Disclosures: Disclosures to report. SNP chips for the GWAS were provided by the Morris Animal Foundation. Elevated serum canine pancreatic lipase immunoreactivity (cPLI) concentrations are highly specific for pancreatitis. Additionally, some studies in dogs with primary gastrointestinal (GI) disease have suggested a negative outcome in dogs with increased serum cPLI concentrations. GI disease, including foreign bodies (FBs) can mimic clinical sig.....
    Document: Disclosures: Disclosures to report. SNP chips for the GWAS were provided by the Morris Animal Foundation. Elevated serum canine pancreatic lipase immunoreactivity (cPLI) concentrations are highly specific for pancreatitis. Additionally, some studies in dogs with primary gastrointestinal (GI) disease have suggested a negative outcome in dogs with increased serum cPLI concentrations. GI disease, including foreign bodies (FBs) can mimic clinical signs of pancreatitis. GI FBs have also been proposed as a risk factor for the development of pancreatitis in dogs. To date the prevalence of pancreatitis in dogs with GI FBs is unknown. The primary aim of this study was to determine the prevalence of elevated cPLI concentrations (as measured by Spec cPL Ã’ ) in dogs with GI FBs, and to correlate Spec cPL concentrations with patient survival. A secondary aim was to compare Spec cPL concentrations among dogs based on age, FB type, FB location, and type of removal procedure.

    Search related documents:
    Co phrase search for related documents
    • FB location and FB type: 1
    • FB location and foreign body: 1